| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |